Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

Abstract

Pharmaceutical compositions comprising compounds of the formula where R 1 , R 2 , and R 3 are described here, have therapeutic utility in selectively inhibiting P. falciparum dihydroorotate dehydrogenase. Accordingly, such compositions have use in the treatment and prevention of malaria.